| 07:00 - 08:15 | 45 | CC1 Life-threatening mediastinitis and TB | Challenging clinical cases |
| 07:00 - 08:15 | 46 | CC2 Interstitial lung diseases | Challenging clinical cases |
| 08:30 - 10:30 | 54 | GR1 Imaging Grand Round | Grand round |
| 08:30 - 10:30 | 55 | State of the art session: "Respiratory infections" | Symposium |
| 08:30 - 10:30 | 56 | Paediatric year in review: update on paediatric pulmonology | Year in review |
| 08:30 - 10:30 | 57 | Pathophysiology and emerging therapies for severe asthma | Session |
| 08:30 - 10:30 | 58 | Tobacco Control in Europe: research and policy | Symposium |
| 08:30 - 10:30 | 59 | Rational strategies for specific treatment situations in lung cancer | Symposium |
| 08:30 - 10:30 | 60 | New developments in respiratory physiotherapy and pulmonary rehabilitation | Symposium |
| 08:30 - 10:30 | 61 | The circadian molecular clock in respiratory diseases and associated interventions | Hot topics |
| 08:30 - 10:30 | 62 | Novel mechanisms and treatments for asthma | Oral Presentation |
| 08:30 - 10:30 | 63 | New Mechanistic Findings in COPD | Oral Presentation |
| 08:30 - 10:30 | 64 | Pleural disease and mesothelioma: from the bench to the bedside | Oral Presentation |
| 08:30 - 10:30 | 65 | New insights into acute critical care | Oral Presentation |
| 08:30 - 10:30 | 66 | Best abstracts in pulmonary rehabilitation and chronic care | Oral Presentation |
| 08:30 - 10:30 | 67 | Asthma and ACOS: predictors and clinical characteristics | Oral Presentation |
| 08:30 - 10:30 | 68 | Risk factors: symptomatology and diagnostic approaches for obstructive sleep apnoea | Poster Discussion |
| 08:30 - 10:30 | 69 | Anti-inflammatory and pro-repair mediators in acute lung injury | Poster Discussion |
| 08:30 - 10:30 | 70 | Best clinical practice for the management of chronic lung diseases | Poster Discussion |
| 08:30 - 10:30 | 71 | Novel molecular and genetic targets in COPD | Poster Discussion |
| 08:30 - 10:30 | 72 | Current challenges in COPD evaluation | Poster Discussion |
| 08:30 - 10:30 | 73 | Shared exposures related to interstitial disease and airflow obstruction | Poster Discussion |
| 10:45 - 12:45 | 79 | GR2 Lung Cancer Grand Round | Grand round |
| 10:45 - 12:45 | 80 | State of the art session: "Rehabilitation, interventional pulmonology and surgery" | Symposium |
| 10:45 - 12:45 | 81 | Sadoul Lecture: "Airway hyperresponsiveness: the riddle of asthma and COPD" and related topics | Session |
| 10:45 - 12:45 | 82 | COPD and comorbid cardiovascular diseases | Symposium |
| 10:45 - 12:45 | 83 | Repair of the emphysematous lung: mesenchymal stromal cell and matrix interactions | Symposium |
| 10:45 - 12:45 | 84 | Translating “evidence-based behaviour change” and “e-health” interventions into practice: what works in smoking cessation and smoking prevention? | Symposium |
| 10:45 - 12:45 | 85 | Multidisciplinary management of sleep apnoea | Symposium |
| 10:45 - 12:45 | 86 | Update on community acquired pneumonia | Oral Presentation |
| 10:45 - 12:45 | 87 | Interstitial lung diseases (ILDs): novel pathogenetic pathways | Oral Presentation |
| 10:45 - 12:45 | 88 | Silicosis has not gone away | Oral Presentation |
| 10:45 - 12:45 | 89 | Innovation in COPD: techniques and facts | Oral Presentation |
| 10:45 - 12:45 | 90 | Determinants of childhood asthma and atopy | Oral Presentation |
| 10:45 - 12:45 | 91 | Towards personalised medicine in COPD: biological and clinical phenotypes | Oral Presentation |
| 10:45 - 12:45 | 92 | The importance of physical activity in patients with COPD | Oral Presentation |
| 10:45 - 12:45 | 93 | Pulmonary drug and devices delivery | Poster Discussion |
| 10:45 - 12:45 | 94 | Pulmonary infection and inflammation | Poster Discussion |
| 10:45 - 12:45 | 95 | Prognostic factors and outcomes in pulmonary embolism | Poster Discussion |
| 10:45 - 12:45 | 96 | "Alarming" immunological patterns in asthma | Poster Discussion |
| 10:45 - 12:45 | 97 | Paediatric asthma: treatment modalities and behavioural issues | Poster Discussion |
| 10:45 - 12:45 | 98 | Nursing practice across respiratory care pathways | Poster Discussion |
| 12:50 - 14:40 | 102 | Clinical points to ponder in asthma | Thematic Poster |
| 12:50 - 14:40 | 103 | Bronchial asthma management | Thematic Poster |
| 12:50 - 14:40 | 104 | COPD management | Thematic Poster |
| 12:50 - 14:40 | 105 | Extrapulmonary comorbidities in COPD | Thematic Poster |
| 12:50 - 14:40 | 106 | Clinical challenges in chronic lung diseases | Thematic Poster |
| 12:50 - 14:40 | 107 | Clinical problems in lung diseases | Thematic Poster |
| 12:50 - 14:40 | 108 | Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases | Thematic Poster |
| 12:50 - 14:40 | 109 | Latest insights into functional capacity, muscle weakness and physical activity in chronic lung diseases | Thematic Poster |
| 12:50 - 14:40 | 110 | Imaging markers for COPD and asthma | Thematic Poster |
| 12:50 - 14:40 | 111 | Endoscopic lung volume reduction (EVLR) and targeted lung denervation (TLD) | Thematic Poster |
| 12:50 - 14:40 | 112 | EBUS | Thematic Poster |
| 12:50 - 14:40 | 113 | ILDs: clinical aspects | Thematic Poster |
| 12:50 - 14:40 | 114 | ILDs: clinical problems | Thematic Poster |
| 12:50 - 14:40 | 115 | The spectrum of CTDs: from pathogenesis to treatment | Thematic Poster |
| 12:50 - 14:40 | 116 | Lung fibrosis: basic science | Thematic Poster |
| 12:50 - 14:40 | 117 | Primary care diagnosis, assessment and management of COPD | Thematic Poster |
| 12:50 - 14:40 | 118 | Primary care pulmonary rehabilitation, multimorbidity and organisation of care | Thematic Poster |
| 12:50 - 14:40 | 119 | Current molecular and genetic understanding of lung diseases | Thematic Poster |
| 12:50 - 14:40 | 120 | Infection and exacerbation science | Thematic Poster |
| 12:50 - 14:40 | 121 | Systemic and airway biomarkers | Thematic Poster |
| 12:50 - 14:40 | 122 | Novel pro- and anti-fibrotic mechanisms in pulmonary fibrosis | Thematic Poster |
| 12:50 - 14:40 | 123 | Towards better treatments for lung disease: experimental pharmacology | Thematic Poster |
| 12:50 - 14:40 | 124 | COPD management | Thematic Poster |
| 12:50 - 14:40 | 125 | Markers of COPD progression | Thematic Poster |
| 12:50 - 14:40 | 126 | Classifying COPD with multidimensional scores and biomarkers | Thematic Poster |
| 12:50 - 14:40 | 127 | Airway disease and exacerbations | Thematic Poster |
| 12:50 - 14:40 | 128 | Animal models of asthma and allergies | Thematic Poster |
| 12:50 - 14:40 | 129 | Novel mechanisms in asthma | Thematic Poster |
| 12:50 - 14:40 | 130 | Lung function, respiratory symptoms and obstructive sleep apnoea | Thematic Poster |
| 12:50 - 14:40 | 131 | COPD: from screening to risk factors of lung cancer | Thematic Poster |
| 12:50 - 14:40 | 132 | Case reports and series | Thematic Poster |
| 12:50 - 14:40 | 133 | Smoking, apnoea, infection, allergens and other factors | Thematic Poster |
| 12:50 - 14:40 | 134 | Passive smoking and epidemiology | Thematic Poster |
| 12:50 - 14:40 | 135 | Smoking cessation | Thematic Poster |
| 12:50 - 14:40 | 136 | What is new in respiratory and sleep physiology? | Thematic Poster |
| 12:50 - 14:40 | 137 | Paediatric asthma: therapies and comorbidities | Thematic Poster |
| 12:50 - 14:40 | 138 | Diagnostic tools in paediatric asthma | Thematic Poster |
| 12:50 - 14:40 | 139 | Cystic fibrosis: clinical issues | Thematic Poster |
| 12:50 - 14:40 | 140 | Late-breaking findings in asthma and COPD | Thematic Poster |
| 13:00 - 14:30 | 141 | Lung cancer for the pulmonologist | Lunchtime session |
| 13:00 - 14:30 | 144 | ERS Research Initiatives | Lunchtime session |
| 13:00 - 14:30 | 145 | Making ERS guidelines usable and relatable | Lunchtime session |
| 13:00 - 14:15 | 149 | Continuing professional development | Educational forum |
| 13:00 - 14:00 | 151 | ME1 Treating obstructive sleep apnoea syndrome in children | Meet the expert |
| 13:00 - 14:00 | 152 | ME3 Genetics, pathology and therapy of neuroendocrine tumours of the lung | Meet the expert |
| 13:00 - 14:00 | 153 | ME4 Chronic cough - FULLY BOOKED | Meet the expert |
| 13:00 - 14:00 | 154 | ME2 Transbronchial cryobiopsy in diffuse parenchymal lung disease | Meet the expert |
| 14:45 - 16:45 | 167 | GR3 Scientific Grand Round: Autoimmunity in chronic lung disease | Grand round |
| 14:45 - 16:45 | 168 | State of the art session: "Paediatric" | Symposium |
| 14:45 - 16:45 | 169 | Difficult indications for lung transplantation | Symposium |
| 14:45 - 16:45 | 170 | Sleep and Breathing | Session |
| 14:45 - 16:45 | 171 | Digital health: transforming the respiratory landscape | Symposium |
| 14:45 - 16:45 | 172 | Bronchiectasis: from guidelines to real life | Session |
| 14:45 - 16:45 | 173 | Noninvasive ventilation (NIV) in acute respiratory failure | Session |
| 14:45 - 16:45 | 174 | ERS statements and technical standards on diagnosis and monitoring | Session |
| 14:45 - 16:45 | 175 | Interventional pulmonology highlights 2017 | Oral Presentation |
| 14:45 - 16:45 | 176 | Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies | Oral Presentation |
| 14:45 - 16:45 | 177 | Many faces of asthma assessment | Oral Presentation |
| 14:45 - 16:45 | 178 | Novel mechanisms and treatments for COPD | Oral Presentation |
| 14:45 - 16:45 | 179 | COPD management: new findings from large studies | Oral Presentation |
| 14:45 - 16:45 | 180 | Cardiac function assessment in pulmonary hypertension | Oral Presentation |
| 14:45 - 16:45 | 181 | Rare diseases | Poster Discussion |
| 14:45 - 16:45 | 182 | Novel treatments for rehabilitation of patients with chronic respiratory diseases | Poster Discussion |
| 14:45 - 16:45 | 183 | From donor lung selection and organ preservation to lung transplant outcome | Poster Discussion |
| 14:45 - 16:45 | 184 | Prevalence, prognosis and comorbidities of COPD and factors associated with lung function | Poster Discussion |
| 14:45 - 16:45 | 185 | Mesothelioma and malignant pleural disease | Poster Discussion |
| 14:45 - 16:45 | 186 | Primary care management of asthma and COPD | Poster Discussion |